Recurrence of Hepatocellular Carcinoma after Direct Acting Antiviral Treatment for Hepatitis C Virus Infection: Literature Review and Risk Analysis

Although studies suggest decreased incident hepatocellular carcinoma (HCC) after treatment with direct-acting antivirals (DAAs) for hepatitis C virus (HCV) infection, data are conflicting regarding risk and aggressiveness of recurrence in patients who have a history of treated HCC. This review analyses data available in literature in order to elucidate the impact of DAAs on the risk of HCC recurrence after successful treatment of the tumor. Overall 24 papers were identified. The available data cannot be considered definitive, but the initial alarmist data indicating an increased risk of recurrence have not been confirmed by most subsequent studies.

from Gastroenterology via xlomafota13 on Inoreader https://ift.tt/2KJWuoF
via IFTTT